ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Activation and Recruitment of GIL During Hp Infection

This study is currently recruiting participants.
Verified by National Taiwan University Hospital, December 2005

Sponsored by: National Taiwan University Hospital
Information provided by: National Taiwan University Hospital
ClinicalTrials.gov Identifier: NCT00275886
  Purpose

Helicobacter pylori is a major human pathogen that infects over half of the world population. Infection initiates a series of changes in the gastric mucosa, beginning with gastritis and leading in some patients to peptic ulcer disease, mucosa-associated lymphomas, and gastric adenocarcinoma. It is believed that host factors, in particular, the T cell-mediated immune responses may play an important role in the pathogenesis of diseases induced by H. pylori infection. Recent results revealed that there were higher IFN-γ secreting cells in gastric infiltrating T cells isolated from H. pylori infected patients than in uninfected patients, suggesting that the TH1 response and degree of IFN-γ production is associated with disease severity. Meanwhile, recent studies have shown that apoptosis of the gastric epithelium is increased during infection and this response is associated with an expansion of gastric T-helper type 1 (Th1) cells. In this project, we are trying to further investigate role of host T cell mediated immune response in pathogenesis of Helicobacter infection by characterization of the expression of chemokine receptors on gastric infiltrating lymphocytes. We are going to investigate the mechanisms involving in chemokine/chemokine receptor interaction in recruitment of gastric infiltrating lymphocytes and pathogenesis of gastric mucosa damage in Helicobacter infection. This study will be helpful for understanding the mechanisms of activation and recruitment of gastric-infiltrating lymphocytes during gastric inflammation.


Condition
Helicobacter Gastritis
Dyspepsia

MedlinePlus related topics:   Indigestion   

U.S. FDA Resources

Study Type:   Observational
Study Design:   Screening, Cross-Sectional, Case Control, Retrospective Study
Official Title:   Activation and Recruitment of Gastric Infiltrating Lymphocytes During H. Pylori Infection

Further study details as provided by National Taiwan University Hospital:

Estimated Enrollment:   30
Study Start Date:   January 2006
Estimated Study Completion Date:   December 2008

Detailed Description:

Specific Aim #1: Characterization of the gastric infiltrating T cells from H. pylori gastritis patients A. Patients H. pylori infected gastritis and asymptomatic patients are selected from National Taiwan University hospital. The gastric biopsy specimen are taken from endoscopic biopsy in routine health check up or panendoscopic examination for the despeptic patients. HP negative gastritis patients will also be studied for negative control.

B. Immunohistochemical identification of T cells and expression of chemokine receptors.

Specific Aim #2 . Isolation and characterization of chemokines and chemokine receptors of the infiltrating lymphocytes in H. pylori-associated gastritis tissue

A. Isolation of gastric infiltrating lymphocyte B. Identification of the expression of chemokine receptor in gastric infiltrating lymphocytes by flow cytometry C. Detection of expression of chemokines in gastric tissues

  Eligibility
Ages Eligible for Study:   20 Years to 60 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Criteria

Inclusion Criteria:

  • patients receiveing endoscopy examination due to dyspepsia

Exclusion Criteria:

  • nil
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00275886

Contacts
Contact: Ping-Ning Hsu, MD, PhD     886-2-23123456 ext 8635     phsu@ha.mc.ntu.edu.tw    

Locations
Taiwan
National Taiwan University Hospital     Recruiting
      Taipei, Taiwan
      Contact: Ping-Ning Hsu, MD, PhD     +886-223123456 ext 8635     phsu@ha.mc.ntu.edu.tw    
      Principal Investigator: Ping-Ning Hsu, MD, PhD            

Sponsors and Collaborators
National Taiwan University Hospital

Investigators
Principal Investigator:     Ping-Ning Hsu, MD, PhD     Department of Immunology    
  More Information


Study ID Numbers:   9461701221
First Received:   January 11, 2006
Last Updated:   January 11, 2006
ClinicalTrials.gov Identifier:   NCT00275886
Health Authority:   Taiwan: Department of Health

Study placed in the following topic categories:
Signs and Symptoms
Stomach Diseases
Digestive System Diseases
Signs and Symptoms, Digestive
Gastrointestinal Diseases
Gastroenteritis
Dyspepsia
Gastritis

ClinicalTrials.gov processed this record on October 15, 2008




Links to all studies - primarily for crawlers